Printer Friendly

Nisshin Seifun, French Boulangerie Maison Kayser to Jointly Introduce Bread Flour for Commercial Use.

Tokyo, Japan, Aug 17, 2005 - (JCNN) - Nisshin Seifun announced on August 17 that it has formed a business alliance with Boulangerie Eric Kayser Japon, a Japanese affiliate of French boulangerie Maison Kayser, and jointly developed special bread flour, Maison Kayser Traditional (MKTD).

MKTD, produced by French baker Eric Kayzer, helps bake traditional French bread with distinctive flavor and taste. The new product will be available on August 22 nationwide.

In addition, Nissin Seifun plans to hold workshops for bakers in October in Tokyo, Osaka and Fukuoka, by invisting Mr. Kayser as a guest.

Source: JCN http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Geographic Code:9JAPA
Date:Aug 18, 2005
Words:109
Previous Article:AnGes MG Patents HVJ Envelope Vector in US.
Next Article:Sumitomo Corp., Summit Medi-Chem Release Fuel Cell Catalyst Capable of Using Ethanol.


Related Articles
Flour power: a guide to buying bread.
Durum doubles for bread and pasta.
Nisshin Seifun Group to Build New Premixed Flour Factory in Qingdao, China.
Nisshin Pharma Begins Production, Marketing of Aqua Q10 P40 Powder for Dietary Supplements.
Mitsubishi Gas Chemical, Nisshin Pharma to Jointly Organize CoQ10 Business.
Nisshin Pharma Confirms that Combination of CoQ10 and Carnitine Helps Reduce Body Fat.
Nisshin Pharma and Others to Co-develop Functional Foods for Alleviating and Preventing Gastric Lesions.
The staff of life: whether by hand or by machinery baking bread is a heartwarming pursuit.
Nisshin OilliO Introduces Two New Foods for Kidney Disease Patients.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |